CannabiNext | Phytonet

500% higher blood concentrations than conventional products

CannabiNext^®

CannabiNext®, developed by İmuneks Farma, uses internationally patented technology to enhance cannabinoid solubility and bioavailability, achieving over 500% higher blood concentrations than conventional products.

Formulated with GRAS excipients approved by global regulatory bodies (FDA, EFSA, KFDA, etc.), CannabiNext® offers rapid onset, extended effects, and versatile application in powder or liquid forms for food, beverage, pharmaceutical, and nutraceutical use.

Key Facts

CannabiNext® is developed by İmuneks Farma using a patented formulation technology that significantly enhances cannabinoid solubility and bioavailability.
CannabiNext® achieves over 500% greater blood concentration compared to conventional cannabinoid products, indicating a substantial improvement in bioavailability.
CannabiNext® utilizes only GRAS (Generally Recognized As Safe) excipients approved by major regulatory authorities, including the U.S. FDA, EFSA, Japan, KFDA, and Chinese FDA, ensuring safety and compliance.
CannabiNext® offers rapid onset and extended duration of effects, making it suitable for various applications.
CannabiNext® is available in convenient powder or liquid formats, suitable for incorporation into foods, beverages, pharmaceutical, and nutraceutical products.

Key Benefits

CannabiNext® achieves up to 32 times higher blood concentration compared to standard CBD formulations, indicating a significant enhancement in bioavailability.
CannabiNext® utilizes only GRAS (Generally Recognized As Safe) excipients approved by major regulatory authorities, including the U.S. FDA, EFSA, Japan, KFDA, and Chinese FDA, ensuring safety and compliance.
CannabiNext® offers rapid onset and extended duration of effects, making it suitable for various applications.
CannabiNext® is available in convenient powder or liquid formats, suitable for incorporation into foods, beverages, pharmaceutical, and nutraceutical products.

*These statements have not been evaluated by the US Food & Drug Administration or the European Food and Safety Authority. This product is not intended to diagnose, treat, cure, or prevent any disease.

Quality

Key Facts

CannabiNext® is developed by İmuneks Farma using a patented formulation technology that significantly enhances cannabinoid solubility and bioavailability.
CannabiNext® achieves over 500% greater blood concentration compared to conventional cannabinoid products, indicating a substantial improvement in bioavailability.
CannabiNext® utilizes only GRAS (Generally Recognized As Safe) excipients approved by major regulatory authorities, including the U.S. FDA, EFSA, Japan, KFDA, and Chinese FDA, ensuring safety and compliance.
CannabiNext® offers rapid onset and extended duration of effects, making it suitable for various applications.
CannabiNext® is available in convenient powder or liquid formats, suitable for incorporation into foods, beverages, pharmaceutical, and nutraceutical products.

Key Benefits

CannabiNext® achieves up to 32 times higher blood concentration compared to standard CBD formulations, indicating a significant enhancement in bioavailability.
CannabiNext® utilizes only GRAS (Generally Recognized As Safe) excipients approved by major regulatory authorities, including the U.S. FDA, EFSA, Japan, KFDA, and Chinese FDA, ensuring safety and compliance.
CannabiNext® offers rapid onset and extended duration of effects, making it suitable for various applications.
CannabiNext® is available in convenient powder or liquid formats, suitable for incorporation into foods, beverages, pharmaceutical, and nutraceutical products.

Quality

Health Indications

Mental Health

To support overall health and complement the diet.

Metabolic Support

Blood Sugar Management.

Sleep Support

To aid in improving sleep quality.

Stress Relief

To help manage stress.

Digestive Health

To aid digestion or relieve digestive issues.

Skin, Hair and Nail Health

To support skin health and appearance.

Probiotics Support

Pre-/Pro-/Post-/Synbiotics Support

Applications

We’ve unveiled the next application method for your product, tailored for optimal use.

CannabiNext® delivers unmatched cannabinoid bioavailability in a convenient, flexible format, making it ideal for once-daily dosing—either as a powerful standalone or within innovative combination formulas.

At Phytonet Pharmaceuticals, we specialize in providing a wide range of forms, ensuring versatility and quality in every solution we offer.

Ready to realize your product’s full potential?

We work closely with our customers and our world-wide suppliers to source and scientifically back innovative ingredients for your product development needs.

Homepage

Ingredients

Pharmaceuticals

Menu